Incidence and Mortality Rates of Keratinocyte Carcinoma from 1998-2017: a Population-based Study of Sex Differences in Ontario, Canada

Overview

Journal CMAJ

Date 2021 Oct 5

PMID 34607845

Citations 10

Authors

Evan Tang

Kinwah Fung

An-Wen Chan

Affiliations

Soon will be listed here.

Abstract

Background: Keratinocyte carcinoma is the most common malignant disease, but it is not captured in major registries. We aimed to describe differences by sex in the incidence and mortality rates of keratinocyte carcinoma in Ontario, Canada.

Methods: We conducted a population-based retrospective study of adults residing in Ontario between Jan. 1, 1998, and Dec. 31, 2017, using linked health administrative databases. We identified the first diagnosis of keratinocyte carcinoma using a validated algorithm of health insurance claims, and deaths related to keratinocyte carcinoma from death certificates. We calculated the incidence and mortality rates of keratinocyte carcinoma, stratified by sex, age and income quintile. We evaluated trends using the average annual percentage change (AAPC) based on joinpoint regression.

Results: After decreasing from 1998 to 2003, the incidence rate of keratinocyte carcinoma increased by 30% to 369 per 100 000 males and 345 per 100 000 females in 2017 (AAPC 1.9%, 95% confidence interval [CI] 1.7 to 2.1 from 2003 to 2017). The incidence rate was higher in females younger than 55 years, but higher in males aged 55 years or older. Between 2008 and 2017, the incidence rate rose faster in females than males aged 45-54 years (AAPC 1.2% v. 0.5%, = 0.01) and 55-64 years (1.2% v. 0.1%, < 0.01). The incidence was higher in males than females in the higher income quintiles. Between 1998 and 2017, the mortality rate of keratinocyte carcinoma was 1.8 times higher in males than females, on average, and rose 4.8-fold overall (AAPC 8.9%, 95% CI 6.4 to 11.4 in males; 8.0%, 95% CI 5.3-10.8 in females).

Interpretation: The population burden of keratinocyte carcinoma is growing, and the incidence and mortality rates rose disproportionately among certain sex- and age-specific groups. This warrants further investigation into causal factors and renewed preventive public health measures.

Citing Articles

Unraveling the controversy: exploring the link between sex hormones and skin cancers through a meta-analysis and systematic review.

Zhao T, Li C, Zhong A, Yun J, Chen J Arch Dermatol Res. 2025; 317(1):292.

PMID: 39825969 DOI: 10.1007/s00403-024-03791-7.

The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations.

Narod S, Metcalfe K, Finch A, Chan A, Randall Armel S, Aeilts A Hered Cancer Clin Pract. 2024; 22(1):7.

PMID: 38741145 PMC: 11089770. DOI: 10.1186/s13053-024-00277-5.

High-throughput lipidomic profiles sampled with electroporation-based biopsy differentiate healthy skin, cutaneous squamous cell carcinoma, and basal cell carcinoma.

Louie L, Wise J, Berl A, Shir-Az O, Kravtsov V, Yakhini Z Skin Res Technol. 2024; 30(5):e13706.

PMID: 38721854 PMC: 11079884. DOI: 10.1111/srt.13706.

Global burden and prediction study of cutaneous squamous cell carcinoma from 1990 to 2030: A systematic analysis and comparison with China.

Huang S, Jiang J, Wong H, Zhu P, Ji X, Wang D J Glob Health. 2024; 14:04093.

PMID: 38695259 PMC: 11063968. DOI: 10.7189/jogh.14.04093.

Top 10 research priorities for cutaneous squamous cell carcinoma: results of the Skin Investigation Network of Canada Priority Setting Initiative.

Lefrancois P, Doueidari Z, Kleiner O, Manion R, Dutz J, Philip A Br J Dermatol. 2023; 190(3):431-432.

PMID: 38114099 PMC: 10873564. DOI: 10.1093/bjd/ljad387.

References

Marcil I, Stern R . Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000; 136(12):1524-30. DOI: 10.1001/archderm.136.12.1524. View

Wu S, Cho E, Li W, Qureshi A . History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study. J Natl Cancer Inst. 2017; 109(4). PMC: 5441298. DOI: 10.1093/jnci/djw268. View

Demers A, Nugent Z, Mihalcioiu C, Wiseman M, Kliewer E . Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol. 2005; 53(2):320-8. DOI: 10.1016/j.jaad.2005.03.043. View

Tokez S, Hollestein L, Louwman M, Nijsten T, Wakkee M . Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. 2020; 156(12):1300-1306. PMC: 7593880. DOI: 10.1001/jamadermatol.2020.3677. View

Lim H, Collins S, Resneck Jr J, Bolognia J, Hodge J, Rohrer T . The burden of skin disease in the United States. J Am Acad Dermatol. 2017; 76(5):958-972.e2. DOI: 10.1016/j.jaad.2016.12.043. View

Loh T, Ortiz A, Goldenberg A, Jiang S . Prevalence and Clinical Characteristics of Nonmelanoma Skin Cancers Among Hispanic and Asian Patients Compared With White Patients in the United States: A 5-Year, Single-Institution Retrospective Review. Dermatol Surg. 2016; 42(5):639-45. DOI: 10.1097/DSS.0000000000000694. View

Kim H, Fay M, Yu B, Barrett M, Feuer E . Comparability of segmented line regression models. Biometrics. 2004; 60(4):1005-14. DOI: 10.1111/j.0006-341X.2004.00256.x. View

Eisemann N, Waldmann A, Geller A, Weinstock M, Volkmer B, Greinert R . Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2013; 134(1):43-50. DOI: 10.1038/jid.2013.304. View

Tam M, Luu M, Barker C, Gharavi N, Hamid O, Shiao S . Improved survival in women versus men with merkel cell carcinoma. J Am Acad Dermatol. 2020; 84(2):321-329. DOI: 10.1016/j.jaad.2020.02.034. View

10.

Brenner D, Ruan Y, Shaw E, OSullivan D, Poirier A, Heer E . Age-standardized cancer-incidence trends in Canada, 1971-2015. CMAJ. 2019; 191(46):E1262-E1273. PMC: 6861145. DOI: 10.1503/cmaj.190355. View

11.

Hall H, MAY D, Lew R, Koh H, Nadel M . Sun protection behaviors of the U.S. white population. Prev Med. 1997; 26(4):401-7. DOI: 10.1006/pmed.1997.0168. View

12.

Karimkhani C, Boyers L, Dellavalle R, Weinstock M . It's time for "keratinocyte carcinoma" to replace the term "nonmelanoma skin cancer". J Am Acad Dermatol. 2014; 72(1):186-7. DOI: 10.1016/j.jaad.2014.09.036. View

13.

Ciazynska M, Kaminska-Winciorek G, Lange D, Lewandowski B, Reich A, Slawinska M . The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep. 2021; 11(1):4337. PMC: 7900109. DOI: 10.1038/s41598-021-83502-8. View

14.

Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D . Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017; 7(2):1-6. PMC: 5424654. DOI: 10.5826/dpc.0702a01. View

15.

Pukkala E, Karvonen J . Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol. 1999; 135(7):781-6. DOI: 10.1001/archderm.135.7.781. View

16.

Schwartz M, Luo L, Berwick M . Sex Differences in Melanoma. Curr Epidemiol Rep. 2020; 6(2):112-118. PMC: 7449145. DOI: 10.1007/s40471-019-00192-7. View

17.

Brenner D, Tammemagi M, Bull S, Pinnaduwaje D, Andrulis I . Using cancer registry data: agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients. Chronic Dis Can. 2009; 30(1):16-9. View

18.

Dennis L, Lowe J, Snetselaar L . Tanning behavior among young frequent tanners is related to attitudes and not lack of knowledge about the dangers. Health Educ J. 2012; 68(3):232-243. PMC: 3374486. DOI: 10.1177/0017896909345195. View

19.

Chan A, Fung K, Tran J, Kitchen J, Austin P, Weinstock M . Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer). JAMA Dermatol. 2016; 152(10):1122-1127. DOI: 10.1001/jamadermatol.2016.2609. View

20.

Pinault L, Fioletov V . Sun exposure, sun protection and sunburn among Canadian adults. Health Rep. 2017; 28(5):12-19. View